(Q42874814)

9 November 2017

title

Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskiren (English)

1 reference

9 November 2017

Effects of High- and Low-Sodium Diets on Ambulatory Blood Pressure in Patients With Hypertension Receiving Aliskiren (English)

1 reference

https://api.crossref.org/works/10.1177/1074248410377173

21 July 2024

author name string

Das Purkayastha

3

1 reference

9 November 2017

Matthew R. Weir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20876343

21 July 2024

Anthony M. Yadao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20876343

21 July 2024

Alan N. Charney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20876343

21 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20876343

21 July 2024

publication date

27 September 2010

1 reference

full work available at URL

9 November 2017

http://journals.sagepub.com/doi/pdf/10.1177/1074248410377173

1 reference

https://api.crossref.org/works/10.1177/1074248410377173

Journal of Cardiovascular Pharmacology and Therapeutics

21 July 2024

published in

1 reference

9 November 2017

volume

15

1 reference

9 November 2017

issue

4

1 reference

9 November 2017

page(s)

356-363

1 reference

National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence

9 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Structure-based design of aliskiren, a novel orally effective renin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

A low-sodium diet potentiates the effects of losartan in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Prognostic value of ambulatory blood pressure : current evidence and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

2007 ESH‐ESC Guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Salt-resistant and salt-sensitive phenotypes determine the sensitivity of blood pressure to weight loss in overweight/obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410377173

Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension

21 January 2018

10

1 reference

https://api.crossref.org/works/10.1177/1074248410377173

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

21 July 2024

15

1 reference

https://api.crossref.org/works/10.1177/1074248410377173

Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives

21 July 2024

17

1 reference

https://api.crossref.org/works/10.1177/1074248410377173

Compliance to a low-salt diet

21 July 2024

23

1 reference

https://api.crossref.org/works/10.1177/1074248410377173

Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study

21 July 2024

26

1 reference

https://api.crossref.org/works/10.1177/1074248410377173

21 July 2024

Identifiers

1 reference

9 November 2017

1 reference